Placental transfer of maternal COVID-19 vaccine-induced antibodies in infants

To profile maternal SARS-CoV-2 vaccine-induced specific antibodies and evaluate their transplacental transfer and persistence in infants at 2, 6, 9, and 12 months of age using systems serology. This study highlights the importance of timing vaccination in pregnancy to provide optimal protection to infants in their first months of life.